Literature DB >> 19706712

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

Adrianus C M Boon1, Jennifer deBeauchamp, Anna Hollmann, Jennifer Luke, Malak Kotb, Sarah Rowe, David Finkelstein, Geoffrey Neale, Lu Lu, Robert W Williams, Richard J Webby.   

Abstract

Despite the prevalence of H5N1 influenza viruses in global avian populations, comparatively few cases have been diagnosed in humans. Although viral factors almost certainly play a role in limiting human infection and disease, host genetics most likely contribute substantially. To model host factors in the context of influenza virus infection, we determined the lethal dose of a highly pathogenic H5N1 virus (A/Hong Kong/213/03) in C57BL/6J and DBA/2J mice and identified genetic elements associated with survival after infection. The lethal dose in these hosts varied by 4 logs and was associated with differences in replication kinetics and increased production of proinflammatory cytokines CCL2 and tumor necrosis factor alpha in susceptible DBA/2J mice. Gene mapping with recombinant inbred BXD strains revealed five loci or Qivr (quantitative trait loci for influenza virus resistance) located on chromosomes 2, 7, 11, 15, and 17 associated with resistance to H5N1 virus. In conjunction with gene expression profiling, we identified a number of candidate susceptibility genes. One of the validated genes, the hemolytic complement gene, affected virus titer 7 days after infection. We conclude that H5N1 influenza virus-induced pathology is affected by a complex and multigenic host component.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706712      PMCID: PMC2753106          DOI: 10.1128/JVI.00514-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection.

Authors:  S Balachandran; P C Roberts; L E Brown; H Truong; A K Pattnaik; D R Archer; G N Barber
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

Review 2.  Forward genetic dissection of immunity to infection in the mouse.

Authors:  S M Vidal; D Malo; J-F Marquis; P Gros
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

3.  Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.

Authors:  Maurizio Mongiat; Giovanni Ligresti; Stefano Marastoni; Erica Lorenzon; Roberto Doliana; Alfonso Colombatti
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

4.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Effect of low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza A virus-induced mortality in mice.

Authors:  Keiko Nohara; Hiroyuki Izumi; Shin ichi Tamura; Ryoichi Nagata; Chiharu Tohyama
Journal:  Toxicology       Date:  2002-01-15       Impact factor: 4.221

6.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.

Authors:  Manfred Kopf; Brian Abel; Awen Gallimore; Michael Carroll; Martin F Bachmann
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

Authors:  Jerry R Aldridge; Carson E Moseley; David A Boltz; Nicholas J Negovetich; Cory Reynolds; John Franks; Scott A Brown; Peter C Doherty; Robert G Webster; Paul G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

9.  IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus.

Authors:  Juan Tan; Wentao Qiao; Jian Wang; Fengwen Xu; Yue Li; Jun Zhou; Qimin Chen; Yunqi Geng
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

10.  TRIM E3 ligases interfere with early and late stages of the retroviral life cycle.

Authors:  Pradeep D Uchil; Brian D Quinlan; Wai-Tsing Chan; Joseph M Luna; Walther Mothes
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  104 in total

1.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Authors:  Ashley L Steed; George P Christophi; Gerard E Kaiko; Lulu Sun; Victoria M Goodwin; Umang Jain; Ekaterina Esaulova; Maxim N Artyomov; David J Morales; Michael J Holtzman; Adrianus C M Boon; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

Review 2.  The contribution of animal models to the understanding of the host range and virulence of influenza A viruses.

Authors:  Christopher D O'Donnell; Kanta Subbarao
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

3.  Genetic control of weight loss during pneumonic Burkholderia pseudomallei infection.

Authors:  Felicia D Emery; Jyothi Parvathareddy; Ashutosh K Pandey; Yan Cui; Robert W Williams; Mark A Miller
Journal:  Pathog Dis       Date:  2014-04-22       Impact factor: 3.166

Review 4.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

5.  Association of Mx1 Asn631 variant alleles with reductions in morbidity, early mortality, viral shedding, and cytokine responses in chickens infected with a highly pathogenic avian influenza virus.

Authors:  Sandra J Ewald; Darrell R Kapczynski; Emily J Livant; David L Suarez; John Ralph; Scott McLeod; Carolyn Miller
Journal:  Immunogenetics       Date:  2011-02-01       Impact factor: 2.846

6.  Genome-wide association identifies diverse causes of common variable immunodeficiency.

Authors:  Jordan S Orange; Joseph T Glessner; Elena Resnick; Kathleen E Sullivan; Mary Lucas; Berne Ferry; Cecilia E Kim; Cuiping Hou; Fengxiang Wang; Rosetta Chiavacci; Subra Kugathasan; John W Sleasman; Robert Baldassano; Elena E Perez; Helen Chapel; Charlotte Cunningham-Rundles; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

7.  Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice.

Authors:  Brittany L DesRochers; Rita E Chen; Anshu P Gounder; Amelia K Pinto; Traci Bricker; Camille N Linton; Corianne D Rogers; Graham D Williams; Richard J Webby; Adrianus C M Boon
Journal:  Virology       Date:  2016-04-20       Impact factor: 3.616

8.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 9.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

10.  A broadly neutralizing human monoclonal antibody is effective against H7N9.

Authors:  Kannan Tharakaraman; Vidya Subramanian; Karthik Viswanathan; Susan Sloan; Hui-Ling Yen; Dale L Barnard; Y H Connie Leung; Kristy J Szretter; Tyree J Koch; James C Delaney; Gregory J Babcock; Gerald N Wogan; Ram Sasisekharan; Zachary Shriver
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.